SomaLogic announces strategic collaboration with University Hospitals Cleveland Medical Center to treat diabetic patients at high risk of cardiovascular disease
November 01, 2021 08:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Nov. 01, 2021 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with one of the nation’s leading...
SomaLogic to Announce Third Quarter 2021 Financial Results
October 28, 2021 16:10 ET
|
SomaLogic, Inc.
BOULDER, Colo., Oct. 28, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the third quarter 2021...
A new study using the SomaScan® Platform makes the connection between genes and proteins and their impact on human disease
October 20, 2021 08:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Oct. 20, 2021 (GLOBE NEWSWIRE) -- In the largest proteogenomic study of its kind to date, an international research team led by scientists at the Berlin Institute of Health at...
SomaLogic Announces Upcoming Conference Participation and Analyst Meeting
September 22, 2021 17:55 ET
|
SomaLogic, Inc.
NEW YORK and BOULDER, Colo., Sept. 22, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today is announcing upcoming conference participation in addition...
SomaLogic Announces Analyst and Investor Meeting on September 28
September 13, 2021 16:10 ET
|
SomaLogic, Inc.
NEW YORK and BOULDER, Colo., Sept. 13, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, will host a virtual Analyst and Investor Meeting on Tuesday,...
SomaLogic announces strategic collaboration with UPMC to tailor clinical care through proteomics technology
September 13, 2021 09:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Sept. 13, 2021 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with leading health system UPMC to...
SomaLogic Reports First Half of 2021 Financial Results
September 08, 2021 19:25 ET
|
SomaLogic, Inc.
NEW YORK and BOULDER, Colo., Sept. 08, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the six months ended June 30,...
SomaLogic to Present at Morgan Stanley 19th Annual Global Healthcare Conference
September 07, 2021 16:10 ET
|
SomaLogic, Inc.
NEW YORK and BOULDER, Colo., Sept. 07, 2021 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the...
SomaLogic Closes Business Combination and Will Begin Trading Under the Ticker “SLGC” on the Nasdaq Stock Exchange
September 01, 2021 12:57 ET
|
SomaLogic, Inc.
SomaLogic to debut on Nasdaq as a leading publicly traded AI-data driven proteomics platform companyBusiness combination results in approximately $630 million in gross cash proceeds to catalyze...
SomaLogic expands leadership team with new positions to drive commercial success
August 31, 2021 16:10 ET
|
SomaLogic, Inc.
NEW YORK and BOULDER, Colo., Aug. 31, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI data-driven proteomics technology, today announced the recent...